sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
entekavir mylan 0,5 mg filmsko obložene tablete
mylan s.a.s. - entekavir - filmsko obložena tableta - entekavir 0,5 mg / 1 tableta - entekavir
entekavir mylan 1 mg filmsko obložene tablete
mylan s.a.s. - entekavir - filmsko obložena tableta - entekavir 1 mg / 1 tableta - entekavir
lopinavir/ritonavir sandoz 200 mg/50 mg filmsko obložene tablete
sandoz d.d. - ritonavir; lopinavir - filmsko obložena tableta - ritonavir 50 mg / 1 tableta lopinavir200 mg / 1 tableta; lopinavir 200 mg / 1 tableta - lopinavir in ritonavir
metformin/glibenklamid lek 500 mg/2,5 mg filmsko obložene tablete
lek d.d. - glibenklamid; metformin - filmsko obložena tableta - glibenklamid 2,5 mg / 1 tableta metformin390 mg / 1 tableta; metformin 390 mg / 1 tableta - metformin in sulfonilsečnine
metformin/glibenklamid lek 500 mg/5 mg filmsko obložene tablete
lek d.d. - glibenklamid; metformin - filmsko obložena tableta - glibenklamid 5 mg / 1 tableta metformin390 mg / 1 tableta; metformin 390 mg / 1 tableta - metformin in sulfonilsečnine
ritonavir sandoz 100 mg filmsko obložene tablete
sandoz d.d. - ritonavir - filmsko obložena tableta - ritonavir 100 mg / 1 tableta - ritonavir
metformin lek 1000 mg filmsko obložene tablete
lek d.d. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin
vitekta
gilead sciences international ltd - elvitegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - vitekta co-upravlja z zaviralec ritonavir povečala proteaze in drugi antiretroviralna sredstva, je indicirano za zdravljenje okužbe človeške imunske pomanjkljivosti-virus-1 (hiv-1) pri odraslih, ki so okuženi s hiv-1 brez znane mutacije povezane z odpornostjo na elvitegravir.
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.